Company Overview and News

 
IMF Raises Its Growth Forecast for Germany: 4 Top Picks

3h zacks
The International Monetary Fund (IMF) recently raised its growth forecast for the German economy. Further, leading economic research institutes in Germany have stated that they expect the country to grow more than they had initially projected in 2018.
Upvote Downvote

 
Auto Stock Roundup: China to Scrap Limit on Foreign Auto JVs, GM to Cut Jobs

2018-04-19 zacks
Somewhat easing the tension of a trade war, China announced that it will erase the limit on foreign ownership of domestic auto ventures. This will assist foreign automakers to own factories in the country. Notably, this restriction has been in place since 1994, which limits foreign carmakers to own not more than 50% share of any local establishment. China will lift foreign ownership limit for the wider car market by 2022.
Upvote Downvote

 
Zacks Investment Ideas feature highlights: Tesla, General Motors, Volkswagen and Toyota

2018-04-19 zacks
Chicago, IL – April 19, 2018 – Today, Zacks Investment Ideas feature highlights Features: Tesla (TSLA - Free Report) , General Motors (GM - Free Report) , Volkswagen (VLKAY - Free Report) and Toyota (TM - Free Report) .
Upvote Downvote

 
Zacks Investment Ideas feature highlights: Fiat Chrysler, Volkswagen AG, Dana and Douglas Dynamics

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Today, Zacks Investment Ideas feature highlights Features: Fiat Chrysler (FCAU - Free Report) , Volkswagen AG (VLKAY - Free Report) , Dana Incorporated (DAN - Free Report) and Douglas Dynamics (PLOW - Free Report) .
Upvote Downvote

 
Sorting Out What Lies Ahead for Tesla (Part 5, the Good, Bad and Ugly in Recent News)

2018-04-18 zacks
Read part 1 here, read part 2 here, read part 3 here, read part 4 here Shares in Tesla (TSLA - Free Report) traded down $3.39 today or 1.2% on a pair of news items with very different potential consequences for the company. Good news about deregulation in the Chinese market probably kept the shares from falling even more after Tesla announced that they were suspending the production of the Model 3 for “four or five days.
Upvote Downvote

 
With Retail Spending on the Rise, Auto Parts and Supplies Look Hot.

2018-04-17 zacks
On Monday, the U.S. Commerce Department released the latest retail sales figures and for the first time in 2018, they were a positive surprise. Retail sales overall were up 4% over the comparable year-ago period. The majority of the gains came from autos and auto supplies. Sales in non-automotive categories were up a modest 0.2%, but Auto Sales surged a full 2%.
Upvote Downvote

 
Tesla's Build Quality Remains High

2018-04-17 seekingalpha
Tesla's warranty accruals had in the past come under intense scrutiny, especially during Model X production hell.
Upvote Downvote

 
Goodyear, Bridgestone to Form JV for Tire Distribution in US

2018-04-17 zacks
The Goodyear Tire & Rubber Company (GT - Free Report) announced that it is entering a 50-50 joint venture (JV) with Bridgestone Americas, Inc. (Bridgestone), which is the U.S. subsidiary of Bridgestone Corporation (BRDCY - Free Report) , to form the largest tire-distribution network in the United States. TireHub LLC, the new JV, will offer a complete range of light-truck and passenger-vehicle tires with primary importance on fulfilling the rising demand for larger rim-diameter premium tires.
Upvote Downvote

 
How North America's Largest Automobile Factory Produces Bargains: Volkswagen Jetta

2018-04-16 seekingalpha
The automobile sales numbers are seeing a huge shift away from sedans and in favor of SUVs and crossovers.
Upvote Downvote

 
Should Investors Believe Elon Musk's Latest Tesla (TSLA) Promise?

2018-04-13 zacks
Shares of Tesla (TSLA - Free Report) popped on Friday after CEO Elon Musk once again took to Twitter (TWTR - Free Report) to boast, this time about the electric car maker’s second half outlook. But at this point, it seems somewhat strange that so many investors still react positively to anything Musk says.
Upvote Downvote

 
Auto Stock Roundup: Xi Jinping to Slash Auto Tariffs, VLKAY to Replace CEO

2018-04-12 zacks
Last week, providing some relief to the growing tension between the U.S. and China, Chinese President Xi Jinping revealed his plans to significantly slash import tariffs on foreign autos and lower duties on other products. Since China accounts for a large part of U.S. auto exports, the comments of Jinping cheered U.S. automakers. On a different note, German auto giant, Volkswagen AG (VLKAY - Free Report) plans to replace its CEO Matthias Mueller, per Reuters.
Upvote Downvote

 
A Look At Tesla's (TSLA) Revenue Growth Over The Last Decade

2018-04-10 zacks
Shares of Tesla (TSLA - Free Report) surged on Tuesday, amid an increasingly volatile period for the company. But while the bear case for the electric car giant gains more steam, it is worth noting just how far Tesla has come over the last 10 years.
Upvote Downvote

 
Volkswagen (VLKAY) Aims to Expand in Brazil with First SUV

2018-04-06 zacks
Per Reuters, Volkswagen AG (VLKAY - Free Report) announced the plan to manufacture its first compact sport utility vehicle (SUV), T-Cross, in Brazil. With this recent development, the company hopes to recover the market shares in the Latin American region. Anticipated to hit the market by the first-half of 2019, Volkswagen announced the plans to invest $595 million (R$ 2 billion) for the production of T-Cross at its Sao Jose dos Pinhais facility, situated in southern Brazil.
Upvote Downvote

 
Musk's U-Turn: Back In Production Hell And Sleeping On Factory Floor

2018-04-03 seekingalpha
Elon sends out bullish email to employees talking about Model 3 production hitting 2,000 per week and sounding very bullish about Model 3 production.
Upvote Downvote

 
New York Auto Show Themes: SUVs, SUVs And More SUVs

2018-04-03 seekingalpha
The New York Auto Show is underway, but the press days are over. I summarize the trends and describe the most important cars and concepts.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 928662303